about
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesA Role for the Brain RAS in Alzheimer's and Parkinson's DiseasesAuditory- and Vestibular-Evoked Potentials Correlate with Motor and Non-Motor Features of Parkinson's Disease.Trust behavior in Parkinson's disease: results of a trust game experiment.Proprioceptive rehabilitation of upper limb dysfunction in movement disorders: a clinical perspective.Alterations of eye movement control in neurodegenerative movement disorders.Diagnosing and treating neurogenic orthostatic hypotension in primary care.Patient-reported Needs, Non-motor Symptoms, and Quality of Life in Essential Tremor and Parkinson's DiseaseA Randomized Controlled Trial of Chinese Medicine on Nonmotor Symptoms in Parkinson's Disease.Use of a self-rating scale of the nature and severity of symptoms in Parkinson's Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity.Motor and Non-Motor Symptoms in Parkinson's Disease: Effects on Quality of Life.Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected.Non-motor and motor features in LRRK2 transgenic mice.Apathy in Parkinson's disease is related to executive function, gender and age but not to depression.Sleep spindle alterations in patients with Parkinson's diseaseSleep Disturbances in Essential Tremor and Parkinson Disease: A Polysomnographic Study.Impaired Early Attentional Processes in Parkinson's Disease: A High-Resolution Event-Related Potentials Study.Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms.Imaging changes associated with cognitive abnormalities in Parkinson's diseaseVisuospatial Attention to Single and Multiple Objects Is Independently Impaired in Parkinson's DiseaseNonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects.α-Synuclein and nonhuman primate models of Parkinson's diseaseParkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.Importance of the brain Angiotensin system in Parkinson's diseaseSensory aspects of movement disorders.Nonmotor Features in Parkinson's Disease: What Are the Most Important Associated Factors?Relationships among Depression, Anxiety, Sleep, and Quality of Life in Patients with Parkinson's Disease in TaiwanTrait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?Emergence of nonmotor symptoms as the focus of research and treatment of Parkinson's disease: introduction to the special section on nonmotor dysfunctions in Parkinson's disease.Psychometric properties of the Italian version of the Scales for Outcomes in Parkinson's disease- Cognition (SCOPA-Cog).The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study GroupEvaluation of non-motor symptoms in Parkinson's Disease: An underestimated necessity.Discussing sexuality with patients with Parkinson's disease: a survey among Dutch neurologists.Pains in Parkinson disease--many syndromes under one umbrella.Urological problems in Parkinson's disease: clinical aspects.Animal models of Parkinson's disease: a gateway to therapeutics?Management of anxiety and motor symptoms in Parkinson's disease.An update on the use of botulinum toxin therapy in Parkinson's disease.Non-motor signs in Parkinson's disease: a review.
P2860
Q26747508-AFBD2D9E-07CD-4CE9-8CDE-1D8305B7CF1AQ26861984-B0DFE4DA-D3C1-4137-900C-F5ACDE906980Q30361239-FA00530E-F9A4-4269-97B6-1216EAF8A9FFQ30405612-D7E90A8A-5FE1-494E-A0F0-3B18D9B73B69Q30423257-4A83C032-DCFC-48CB-BAAE-4AB5C65E4C9FQ30436300-F564B5C3-F5DC-4749-989B-0F49C08F992DQ33165773-BBA87CFA-1B0E-4F1C-B3A0-CA22367A4DB7Q33728967-A1C4EBF0-495B-40FD-BBAA-C391DEDF553FQ33775708-6FCE53E8-D629-42B2-B1B3-18A0B8E2AB71Q33807815-383C73D9-45EC-4D23-81E3-032E08F83A7CQ33854899-F5721618-58CC-4F79-8071-F815CAEB182EQ34239492-D46B2E7B-24EC-4E98-BD27-4DA69441BBAEQ34922393-9AED7668-EDFB-4145-BE3F-4D8005D7C4D3Q34969055-684CA296-3764-412F-AB48-95B9038436B3Q35559845-96D71A2E-7FC5-4A2D-AD15-1E5F75E0900EQ35640468-B1489973-837C-440C-8448-5CEDEA8D8AB6Q35681232-7F76DC33-27B0-498A-BCD1-9744052C026DQ35761258-2E8C380B-F962-4AA8-B374-EC9ADBCD5C5FQ35797763-11A08D77-24DD-49F1-A170-DEE2C150B7EFQ35952366-1FBD5B79-D134-4E11-9ED2-99A8CA8E3DB8Q36135045-500D535B-BC17-4DB4-A623-A27B66805E62Q36157306-3B10B831-2118-454F-82A7-45EFBC9C8B6EQ36351543-66A3DB6D-8416-4B2C-8C07-EA3565EE2C87Q36415423-67EBB98A-5EFB-4BD6-8DF8-64F34FDC1B8AQ36595746-95047873-76D9-4277-8E1E-5D368E2ABF8EQ36861043-93E1EC64-5114-4EBA-A27C-A1974097E151Q36945743-B090C97C-CC90-44FD-8E04-08FFA32E0122Q36946063-44A183A2-7856-4540-A5AB-CB5F8215A822Q37115650-88E8C0AA-F2E9-4AE9-902C-2AAE6E22A5A1Q37136542-A4430D72-E5E8-42D5-92FF-BAC3964481F5Q37267134-EC72E4F3-BD20-46E0-81B0-2CC5104E11CDQ37338662-C85C7663-9E6B-45BD-9660-006D662CD3AFQ37413369-09CAE691-5926-4DAD-AE57-159E527543E8Q37643414-3371554F-97B5-4CDD-9649-1EF9006754EEQ38003055-5AD94763-7F18-47E4-A993-183D21249A38Q38063778-0602C0DD-14D6-4FCF-9D44-410F0A4B20D9Q38155480-11823FFD-D056-45F1-95A0-7D43977B60DFQ38233285-61E6D7E0-0175-4BED-869A-566211A861F2Q38269292-136DF331-5157-4A0B-97CB-A6366C723C69Q38448936-6015EFD8-27FF-4164-9CB2-8D8C0B2B1FB6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Parkinson's disease: the non-motor issues.
@en
Parkinson's disease: the non-motor issues.
@nl
type
label
Parkinson's disease: the non-motor issues.
@en
Parkinson's disease: the non-motor issues.
@nl
prefLabel
Parkinson's disease: the non-motor issues.
@en
Parkinson's disease: the non-motor issues.
@nl
P50
P1476
Parkinson's disease: the non-motor issues.
@en
P304
P356
10.1016/J.PARKRELDIS.2011.02.018
P577
2011-07-08T00:00:00Z